Keywords
primary palliative diagnosis
comorbidity
How to Cite
Abstract
In press
Background. Palliative and Hospice Care (PHC) aims to prevent premature death of patients from complications of serious illnesses and their comorbid impact on vital functions. As well as adequate pain relief, treatment should be aimed at alleviating suffering and improving the quality of life of such patients. The causes of death of palliative patients, which are closely related to the PHC organization, in particular to the package budget financing of inpatient and mobile palliative care for adults and children, the leading needs of palliative patients, remain insufficiently studied.
Aim. Analysis of the main causes of death of palliative patients depending on the diagnosis and determination of their impact on the organization of palliative and hospice care.
Materials and Methods. The method of system analysis, comparative method and bibliosemantic method were used for the research.
Results and Conclusions. Causes of death were studied for diseases listed as palliative in severe cases and in the presence of complications. The analysis allows us to deepen our understanding of the practical aspects of organizing palliative and hospice care in meeting the needs of palliative patients, adults and children. The summary of the causes of death allows us to group these causes into organ and system failure; vascular crises; asphyxia; thromboembolic conditions; infectious complications up to sepsis; chronic intoxication; tumor growth in other organs with disruption of their vital functions, metastasis; malignancy of benign tumors; complications of treatment; brain and spinal cord lesions due to epileptic seizures, injuries, inflammatory processes; endocrine comas; gangrene and bedsores; severe immunodeficiency; underdevelopment or absence of organs in congenital malformations; prematurity; suicides in depressive states.
Keywords: palliative and hospice care, primary palliative diagnosis, comorbidity.
References
Holovanova IA, Shevchenko AS. The issue of patient-oriented organization of palliative and hospice care in Ukraine. Experimental and Clinical Medicine. 2021;90(2):21-7. DOI: 10.35339/ekm.2021.90.2.hos.
Nesterenko VG. The controllability of pain in palliative medicine as a factor in the medical and social impact on the patients’ quality of life at the end-of-life. Experimental and Clinical Medicine. 2024;93(1):69-86. DOI: 10.35339/ekm.2024.93.1.nes. [In Ukrainian].
Smiianov VA. Medical assistance in dying for palliative patients in different countries of the world: lessons on euthanasia legalization. Inter Collegas. 2024;11(2):32-40. DOI: 10.35339/ic.11.2.smi.
Nesterenko VG, Shevchenko AS, Zelenska KO, Hryhorov MM. Clinical and epidemiological characteristics of disabling neurological diseases (literature review). International Neurological Journal. 2024;20(4):176-84. DOI: 10.22141/2224-0713.20.4.2024.1079. [In Ukrainian].
Kluger BM, Hudson P, Hanson LC, Buzgova R, Creutzfeldt CJ, Gursahani R, et al. Palliative care to support the needs of adults with neurological disease. Lancet Neurol. 2023;22(7):619-31. DOI: 10.1016/S1474-4422(23)00129-1. Erratum in: Lancet Neurol. 2023;22(10):e11. DOI: 10.1016/S1474-4422(23)00310-1. PMID: 37353280.
Lekhan VM. Impact of different types of pain on organizational decisions in palliative medicine. Medicine Today and Tomorrow. 2024;93(1):47-55. DOI: 10.35339/msz.2024.93.1.lvm.
Nesterenko VG, Mykhnevych KG. Practical aspects of pain relief in palliative medicine. Inter Collegas. 2024;11(1):57-72. DOI: 10.35339/ic.11.1.nem.
Holovanova IA, Shevchenko AS. Determination of the main needs of palliative patients and ways of their provision in the health care system of Ukraine. Experimental and Clinical Medicine. 2021;90(3):88-94. DOI: 10.35339/ekm.2021.90.3.hos.
Lekhan VM. The importance of medical cannabis for solving the problem of providing analgesia to palliative patients in Ukraine. Experimental and Clinical Medicine. 2024;93(1):87-93. DOI: 10.35339/ekm.2024.93.1.lvm.
Wijdicks EF, Varelas PN, Gronseth GS, Greer DM; American Academy of Neurology. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(23):1911-8. DOI: 10.1212/WNL.0b013e3181e242a8. PMID: 20530327.
Shevchenko AS, Brown GW. What evidence-based medicine can oppose to falsifications in science. Bull KhRIPHS. 2020;96(4):24-35 DOI: 10.5281/zenodo.5076629. [In Ukrainian].
Nesterenko VG, Burzyńska J. Justification of the model of optimized system of providing palliative and hospice care to the population of Ukraine. Inter Collegas. 2024;11(3):10p. In press. DOI: 10.35339/ic.11.3.neb.
The need for palliative care: an assessment based on 2018 data. Ukrainian Center for Public Data. [Internet]. Available at: https://socialdata.org.ua/palliative/ [accessed 20 Dec 2024]. [In Ukrainian].
Nesterenko VG. The need for palliative and hospice care in Ukraine in 2018–2020. Medicine Today and Tomorrow. 2021;90(3):43-52. DOI: 10.35339/msz.2021.90.3.nes. [In Ukrainian].
Nesterenko VG. Forecasting the need for palliative and hospice care in Ukraine for 2021–2022. Experimental and Clinical Medicine. 2021;90(4):25-34. DOI: 10.35339/ekm.2021.90.4.nes. [In Ukrainian].
Nesterenko VG, Redka IV, Sukhonosov RO, Grygorov SM, Shevchenko AS, Aliieva TD. Forecasting the need for palliative and hospice care using the creeping trend method with segment smoothing. Wiad Lek. 2024;77(5):980-4. DOI: 10.36740/WLek202405116. PMID: 39008586.
Nesterenko VG, Shevchenko VV. Calculation of the national need for palliative care by the refined method of trends in the conditions of a military crisis. Eastern Ukrainian Medical Journal. 2024;12(3):711-20. DOI: 10.21272/eumj.2024;12(3):711-720.
Nesterenko VH, Peresypkina TV, Shevchenko OS, Sarkhadova II. Palliative and hospice care in the Kharkiv region in the first year of the war. Ukraine. Nation's Health. 2023;73(3):106-12. DOI: 10.32782/2077-6594/2023.3/18.
Nesterenko VG, Sarkhadova II. Palliative and hospice care for adults in the Kharkiv Regional Center of Palliative Medicine "Hospice" in 2016–2022. Experimental and Clinical Medicine. 2023;92(2):58-68. DOI: 10.35339/ekm.2023.92.2.nes. [In Ukrainian].
Nesterenko VG. Peculiarities of using the SF-36 questionnaire in palliative neurological patients. Medicine Today and Tomorrow. 2023;92(2):62-72. DOI: 10.35339/msz.2023.92.2.nes. [In Ukrainian].
Nesterenko VG. Peculiarities of using the SF-36 questionnaire in palliative oncological patients. Experimental and Clinical Medicine. 2023;92(3):73-85. DOI: 10.35339/ekm.2023.92.3.nes. [In Ukrainian].
Nesterenko VG, Lytvynenko OYu. Readiness for dialogue regarding euthanasia of palliative patients in Ukraine. Experimental and Clinical Medicine. 2024;93(2):79-88. DOI: 10.35339/ekm.2024.93.2.nel. [In Ukrainian].
Titko EV, Deineko OV. Euthanasia / suicide tourism as the human rights protection phenomenon in the present time. Academic notes of the V.I. Vernadsky Tavrida National University. Series: Legal Sciences. 2020;31(70(2(3))):227-32. DOI: 10.32838/2707-0581/2020.2-3/36. [In Ukrainian].
Shevchenko AS, Kuts YuV, Gavrylova SA, Gavrylov EV. Legislative, historical and practical aspects of phenomena that potentially violate the right to life. Bull KhRIPHS. 2020;93(1):20-7. DOI: 10.5281/zenodo.3960410. [In Ukrainian].
Nesterenko VG, Krasnikova SO, Shevchenko AS. Media discussions about hospice and palliative care in Ukraine since the beginning of the war. Proceedings of the VI-th scientific and practical conference with international participation "Public health in Ukraine: problems and ways to solve them", dedicated to the 100-th anniversary of the department of public health and health care management of the Kharkiv National Medical University (Tomilin's readings), 2 Nov 2023. 4 p. DOI: 10.5281/zenodo.10053065.
Holovanova IA, Shevchenko AS. Evaluation of packaged funding programs for palliative and hospice care by the National Health Service of Ukraine. Experimental and Clinical Medicine. 2021;90(4):45-52. DOI: 10.35339/ekm.2021.90.4.hos.
Ortega CE, Seidner Y, Dominguez I. Mining CK2 in cancer. PLoS One. 2014;9(12):e115609. DOI: 10.1371/journal.pone.0115609. Erratum in: PLoS One. 2015;10(3):e0120224. DOI: 10.1371/journal.pone.0120224. PMID: 25541719.
Yao N, Sun X. Challenges and Opportunities to Conduct Cancer Care Research in China: Experience from a Pilot Project. China Health Rev. 2014;5(2):4-9. PMID: 25664325.
Mishchenko M, Shevchenko A, Mishchenko A. Key directions in the organization of health care and prevention actions to reduce mortality from cardiovascular diseases in Ukraine. Abstracts of XVI international scientific and practical conference "Prospects for the development of modern science and practice" (Graz, Austria, 11 May 2020). P. 80-2. DOI: 10.5281/zenodo.3820773.
Ognev VA, Mishchenko MM, Mishchenko AN, Shevchenko AS. World strategy on tobacco control and mortality from cardiovascular diseases in Ukraine. Abstracts of the 2nd International scientific and practical conference "Modern science: problems and innovations" (Stockholm, Sweden, 03–05 May 2020). SSPG Publish. P. 102-8. DOI: 10.5281/zenodo.3787953.
Mishchenko MM, Shevchenko AS, Mishchenko AN. Risk factors of ishemic stroke and their interconnection. Dynamics of the development of world science: Abstracts of the 8th International scientific and practical conference (Vancouver, Canada, 15-17 April 2020). Publishing House "ACCENT". P. 124-9. DOI: 10.5281/zenodo.3755806.
Ognev VA, Mishchenko MM, Mishchenko AN, Shevchenko AS. About value and study of the various risk factors for the development of a cerebral stroke. Topical issues of the development of modern science: Abstracts of the 8th International scientific and practical conference (Sofia, Bulgaria, 08-10 Apr 2020). Publishing House "ACCENT". P. 62-9. DOI: 10.5281/zenodo.3747558.
Mishchenko MM, Mishchenko AN, Shevchenko AS. On the study of risk factors for cardiovascular diseases. Proceedings of the XIХ International Scientific and Practical Conference "Modern Science and its Impact on Humanity Development" (Ukraine, Kharkiv, 28 Feb 2020). Bull KhRIPHS. 2020;93(1):60-1. DOI: 10.5281/zenodo.4005972.
Picard G, Bier JC, Capron I, De Deyn PP, Deryck O, Engelborghs S, et al. Dementia, End of Life, and Euthanasia: A Survey Among Dementia Specialists Organized by the Belgian Dementia Council. J Alzheimers Dis. 2019;69(4):989-1001. DOI: 10.3233/JAD-181277. PMID: 31127774.
Enroth L, Raitanen J, Hervonen A, Nosraty L, Jylha M. Is socioeconomic status a predictor of mortality in nonagenarians? The vitality 90+ study. Age Ageing. 2015;44(1):123-9. DOI: 10.1093/ageing/afu092. PMID: 25002455.
Fairthorne J, Hammond G, Bourke J, Jacoby P, Leonard H. Early mortality and primary causes of death in mothers of children with intellectual disability or autism spectrum disorder: a retrospective cohort study. PLoS One. 2014;9(12):e113430. DOI: 10.1371/journal.pone.0113430. PMID: 25535971.
Holland JN, Schmidt AT. Static and Dynamic Factors Promoting Resilience following Traumatic Brain Injury: A Brief Review. Neural Plast. 2015;2015:902802. DOI: 10.1155/2015/902802. PMID: 26347352.
Bely SN, Yeskova LI, Shevchenko AS. HIV: the history of detection, tropism and methods of immunization. Red Ribbon: Journal for medical workers and AIDS service organizations. 2000;(2):15-9. DOI: 10.5281/zenodo.3715389.
Cambier CJ, Falkow S, Ramakrishnan L. Host evasion and exploitation schemes of Mycobacterium tuberculosis. Cell. 2014;159(7):1497-509. DOI: 10.1016/j.cell.2014.11.024. PMID: 25525872.
Field N, Lim MS, Murray J, Dowdeswell RJ, Glynn JR, Sonnenberg P. Timing, rates, and causes of death in a large South African tuberculosis programme. BMC Infect Dis. 2014;14:3858. DOI: 10.1186/s12879-014-0679-9. PMID: 25528248.
Belayneh M, Giday K, Lemma H. Treatment outcome of human immunodeficiency virus and tuberculosis co-infected patients in public hospitals of eastern and southern zone of Tigray region, Ethiopia. Braz J Infect Dis. 2015;19(1):47-51. DOI: 10.1016/j.bjid.2014.09.002. PMID: 25467923.
Das S, Tucker I, Stewart P. Inhaled dry powder formulations for treating tuberculosis. Curr Drug Deliv. 2015;12(1):26-39. DOI: 10.2174/1567201811666140716123050. PMID: 25030114.
Salazar-Austin N, Dowdy DW, Chaisson RE, Golub JE. Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration. Am J Epidemiol. 2019;188(12):2078-2085. DOI: 10.1093/aje/kwz172. PMID: 31364692.
Jelinska A, Zajac M, Dadej A, Tomczak S, Geszke-Moritz M, Muszalska-Kolos I. Tuberculosis – Present Medication and Therapeutic Prospects. Curr Med Chem. 2020;27(4):630-56. DOI: 10.2174/0929867325666181120100025. PMID: 30457045.
Global tuberculosis report 2024. Geneva: World Health Organization; 2024. 69 p. Available at: https://iris.who.int/bitstream/handle/10665/379339/9789240101531-eng.pdf
Rijal A, Nielsen EE, Hemmingsen B, Neupane D, Gæde PH, Olsen MH, Jakobsen JC. Adding exercise to usual care in patients with hypertension, type 2 diabetes mellitus and/or cardiovascular disease: a protocol for a systematic review with meta-analysis and trial sequential analysis. Syst Rev. 2019;8(1):330. DOI: 10.1186/s13643-019-1233-z. PMID: 31847918.
Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Park YB, et al. Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study. Mod Rheumatol. 2020;30(1):70-7. DOI: 10.1080/14397595.2018.1558760. PMID: 30557057.
Avouac J, Degrave R, Vergneault H, Combier A, Wanono S, Boisson M, et al. Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index. Clin Exp Rheumatol. 2022;40(1):150-7. DOI: 10.55563/clinexprheumatol/usddjr. PMID: 33938795.
Uzun GS, Bulat B, Ayan G, Kılıc L, Kalyoncu U. Liver fibrosis in inflammatory arthritis patients treated with methotrexate and hydroxychloroquine: A FIB-4 index analysis. Int J Rheum Dis. 2024;27(10):e15390. DOI: 10.1111/1756-185X.15390. PMID: 39439367.
Cannon MD, Martin P, Carrion AF. Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death. Dig Dis Sci. 2020;65(1):31-7. DOI: 10.1007/s10620-019-05943-6. PMID: 31768880.
European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents with Human Immunodeficiency Virus in Europe and Thailand: Cohort Study. Clin Infect Dis. 2020;70(3):404-15. DOI: 10.1093/cid/ciz253. PMID: 30919882.
Hussein M, Dibaba B, Wondu Y. Factors Influencing Effectiveness of Peer Education Against Nonadherence to Antiretroviral Therapy Among Adult People Living with HIV/AIDS: A Pre-Post Intervention Study in Arsi Zone, Ethiopia. HIV AIDS (Auckl). 2020;12:1-7. DOI: 10.2147/HIV.S228330. PMID: 32021482.
Ogard-Repal A, Berg RC, Fossum M. Peer Support for People Living With HIV: A Scoping Review. Health Promot Pract. 2023;24(1):172-90. DOI: 10.1177/15248399211049824. PMID: 34693785.
Haque MA. Seasonal Incidence of Community-acquired Pneumonia: A Retrospective Study in a Tertiary Care Hospital in Kathmandu, Nepal. Cureus. 2019 Dec 18;11(12):e6417. DOI: 10.7759/cureus.6417. PMID: 31988818.
Allen JL. Airway function throughout the lifespan: Pediatric origins of adult respiratory disease. Pediatr Investig. 2019;3(4):236-44. DOI: 10.1002/ped4.12165. PMID: 32851329.
Lin WY, Verma VK, Lee MY, Lin HC, Lai CS. Prediction of 30-Day Readmission for COPD Patients Using Accelerometer-Based Activity Monitoring. Sensors (Basel). 2019;20(1):217. DOI: 10.3390/s20010217. PMID: 31905995.
Ogata-Suetsugu S, Hamada N, Tsuda T, Takata S, Kitasato Y, Inoue N, et al.; Fukuoka tobacco-related lung disease (FOLD) registry study group, Fukuoka, Japan. Characteristics of tobacco-related lung diseases in Fukuoka Prefecture, Japan: A prospective, multi-institutional, observational study. Respir Investig. 2020;58(1):74-80. DOI: 10.1016/j.resinv.2019.10.002. PMID: 31727581.
Provenzano M, Coppolino G, Faga T, Garofalo C, Serra R, Andreucci M. Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer. Rev Cardiovasc Med. 2019 Dec;20(4):209-20. DOI: 10.31083/j.rcm.2019.04.548. PMID: 31912712.
Navaneethan SD, Schold JD, Arrigain S, Kirwan JP, Nally JV Jr. Body mass index and causes of death in chronic kidney disease. Kidney Int. 2016;89(3):675-82. doi: 10.1016/j.kint.2015.12.002. PMID: 26880461.
Bhandari SK, Zhou H, Shaw SF, Shi J, Tilluckdharry NS, Rhee CM, et al. Causes of Death in End-Stage Kidney Disease: Comparison between the United States Renal Data System and a Large Integrated Health Care System. Am J Nephrol. 2022;53(1):32-40. DOI: 10.1159/000520466. PMID: 35016183.
Aune D, Sun X, Nie J, Huang W, Liao B, Wang Y. Self-reported chronic kidney disease and the risk of all-cause and cause-specific mortality: outcome-wide association study of 54 causes of death in the National Health Interview Survey. BMC Nephrol. 2022 Apr 30;23(1):165. DOI: 10.1186/s12882-022-02771-1. PMID: 35488232.
Banshodani M, Kawanishi H, Moriishi M, Shintaku S, Tsuchiya S. Association between Dialysis Modality and Cardiovascular Diseases: A Comparison between Peritoneal Dialysis and Hemodialysis. Blood Purif. 2020;49(3):302-9. DOI: 10.1159/000504040. PMID: 31851981.
Ramos AM, Fernandez-Fernandez B, Perez-Gomez MV, Carriazo Julio SM, Sanchez-Nino MD, Sanz A, et al. Design and optimization strategies for the development of new drugs that treat chronic kidney disease. Expert Opin Drug Discov. 2020;15(1):101-115. DOI: 10.1080/17460441.2020.1690450. PMID: 31736379.
Martin C, Hamard C, Kanaan R, Boussaud V, Grenet D, Abely M, et al. Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies! J Cyst Fibros. 2016;15(2):204-12. DOI: 10.1016/j.jcf.2015.09.002. PMID: 26391389.
Zang X, Monge ME, Gaul DA, McCarty NA, Stecenko A, Fernandez FM. Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations by Exhaled Breath Condensate Metabolomics. J Proteome Res. 2020;19(1):144-52. DOI: 10.1021/acs.jproteome.9b00443. PMID: 31621328.
Rosser BA, Chan C, Hoschtitzky A. Surgical Management of Valvular Heart Disease in Mucopolysaccharidoses: A Review of Literature. Biomedicines. 2022;10(2):375. DOI: 10.3390/biomedicines10020375. PMID: 35203584.
Thomas S, Ramaswami U, Cleary M, Yaqub M, Raebel EM. Gastrointestinal Manifestations in Mucopolysaccharidosis Type III: Review of Death Certificates and the Literature. J Clin Med. 2021;10(19):4445. DOI: 10.3390/jcm10194445. PMID: 34640463.
Eskedal LT, Hagemo PS, Eskild A, Frøslie KF, Seiler S, Thaulow E. A population-based study relevant to seasonal variations in causes of death in children undergoing surgery for congenital cardiac malformations. Cardiol Young. 2007;17(4):423-31. DOI: 10.1017/S1047951107000881. PMID: 17583596.
Dodge OG, McKinney B. Causes of perinatal death in uganda africans, with special reference to congenital malformations. J Pediatr. 1964;65:267-9. DOI: 10.1016/s0022-3476(64)80529-1. PMID: 14198801.
Agrawal A, Swaminathan S, Guvvala SL, Gorla SR. Border Medicine: The Pediatric Cardiology Perspective. Pediatr Cardiol. 2020;41(1):202-5. DOI: 10.1007/s00246-019-02171-7. PMID: 31342117.
Szot JO, Campagnolo C, Cao Y, Iyer KR, Cuny H, Drysdale T, et al. Bi-allelic Mutations in NADSYN1 Cause Multiple Organ Defects and Expand the Genotypic Spectrum of Congenital NAD Deficiency Disorders. Am J Hum Genet. 2020 Jan 2;106(1):129-136. DOI: 10.1016/j.ajhg.2019.12.006. PMID: 31883644.
Almli LM, Ely DM, Ailes EC, Abouk R, Grosse SD, Isenburg JL, et al. Infant Mortality Attributable to Birth Defects – United States, 2003–2017. MMWR Morb Mortal Wkly Rep. 2020;69(2):25-9. DOI: 10.15585/mmwr.mm6902a1. PMID: 31945037.
Dangel T, Wojciechowska U. New catalogue of conditions that may require pediatric palliative care. Przegl Epidemiol. 2020;74(3):503-20. DOI: 10.32394/PE.74.44. PMID: 33576589.
Lemmon ME, Bonifacio SL, Shellhaas RA, Wusthoff CJ, Greenberg RG, Soul JS, et al.; Neonatal Seizure Registry. Characterization of Death in Infants with Neonatal Seizures. Pediatr Neurol. 2020;113:21-5. DOI: 10.1016/j.pediatrneurol.2020.08.002. PMID: 32980743.
Barry A, Prentice T, Wilkinson D. End-of-life care over four decades in a quaternary neonatal intensive care unit. J Paediatr Child Health. 2023;59(2):341-5. DOI: 10.1111/jpc.16296. PMID: 36495233.
Reddihough DS, Baikie G, Walstab JE. Cerebral palsy in Victoria, Australia: mortality and causes of death. J Paediatr Child Health. 2001;37(2):183-6. DOI: 10.1046/j.1440-1754.2001.00644.x. PMID: 11328476.
Peterson MD, Wilson AM, Hurvitz EA. Underlying Causes of Death among Adults with Cerebral Palsy. J Clin Med. 2022;11(21):6333. DOI: 10.3390/jcm11216333. PMID: 36362560.
Durufle-Tapin A, Colin A, Nicolas B, Lebreton C, Dauvergne F, Gallien P. Analysis of the medical causes of death in cerebral palsy. Ann Phys Rehabil Med. 2014;57(1):24-37. DOI: 10.1016/j.rehab.2013.11.002. PMID: 24341986.
Alotaibi AS, Mahroos RA, Al Yateem SS, Menezes RG. Central Nervous System Causes of Sudden Unexpected Death: A Comprehensive Review. Cureus. 2022;14(1):e20944. DOI: 10.7759/cureus.20944. PMID: 35004089.
Ekkert A, Saulyte M, Jatuzis D. Inflammatory Disorders of the Central Nervous System Vessels: Narrative Review. Medicina (Kaunas). 2022;58(10):1446. DOI: 10.3390/medicina58101446. PMID: 36295606.
Nageshwaran S, Wilson HC, Dickenson A, Ledingham D. (Eds.). Inflammatory disorders of the central nervous system. P. 77-94. In: Drugs in Neurology. Oxford: Oxford Academic; 2016. DOI: 10.1093/med/9780199664368.003.0006.
Beghi E. The Epidemiology of Epilepsy. Neuroepidemiology. 2020;54(2):185-91. DOI: 10.1159/000503831. PMID: 31852003.
Auzmendi J, Puchulu MB, Rodriguez JCG, Balaszczuk AM, Lazarowski A, Merelli A. EPO and EPO-Receptor System as Potential Actionable Mechanism for the Protection of Brain and Heart in Refractory Epilepsy and SUDEP. Curr Pharm Des. 2020;26(12):1356-64. DOI: 10.2174/1381612826666200219095548. PMID: 32072891.
Sumelahti ML, Hakama M, Elovaara I, Pukkala E. Causes of death among patients with multiple sclerosis. Mult Scler. 2010;16(12):1437-42. DOI: 10.1177/1352458510379244. PMID: 20826526.
Cutter GR, Zimmerman J, Salter AR, Knappertz V, Suarez G, Waterbor J, et al. Causes of death among persons with multiple sclerosis. Mult Scler Relat Disord. 2015 Sep;4(5):484-90. DOI: 10.1016/j.msard.2015.07.008. PMID: 26346799.
Karamyan A, Brandtner H, Grinzinger S, Chroust V, Bacher C, Otto F, et al. Causes of death in critically ill multiple sclerosis patients. Acta Neurol Scand. 2017;136(4):305-9. DOI: 10.1111/ane.12724. PMID: 28008594.
Chou IJ, Kuo CF, Tanasescu R, Tench CR, Tiley CG, Constantinescu CS, Whitehouse WP. Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality. Eur J Neurol. 2020;27(1):105-12. DOI: 10.1111/ene.14040. PMID: 31309645.
Shevchenko AS, Shevchenko VV, Brown GW. The preventive direction of modern theories of health and health-saving in public health and education. Inter Collegas. 2024;11(1):45-51. DOI: 10.35339/ic.11.1.ssb.
Alieva TD, Shevchenko AS. On the issue of reproductive losses prevention in Ukraine. Inter Collegas. 2021;8(1):59-66. DOI: 10.35339/ic.8.1.59-66.
Shevchenko AS, Shevchenko VV, Shumskyi OL, Brown GW, Kucherenko SM, Kucherenko NS, Gavrylov EV. Motivational and regulatory instruments of valeological education. Inter Collegas. 2024;11(3):45-52. DOI: 10.35339/ic.11.3.sss.
Shevchenko A, Kucherenko S, Komyshan A, Shevchenko V, Kucherenko N. Formation of valeological competence in conditions of classroom and distance learning. Scientific Notes of the Pedagogical Department. 2022;(50):137-47. DOI: 10.26565/2074-8167-2022-50-14.
Smiianov VA, Zaitseva HS, Kurganskaya VA, Dyachenko AG, Zbarazhskyi VP, Smiianov YV, Pilipec OA. Vaccination coverage rates and the incidence of vaccine preventable diseases among children in sumy region of Ukraine. Wiad Lek. 2019;72(2):255-60. PMID: 30903783.
Golovanova IA, Smiianov VA, Khorosh MV, Smiianov YV, Smiianova LI. Risk factors of smoking among students of higher medical educational establishments of Ukraine. Wiad Lek. 2018;71(6):1175-81. PMID: 30267496.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.